| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.050 | 82.707 | 0 | 5.679 | 40.433 | 10.047 |
| Total Income - EUR | - | - | - | - | 7.050 | 82.707 | 1.458 | 6.179 | 40.433 | 10.047 |
| Total Expenses - EUR | - | - | - | - | 34 | 9.930 | 5.110 | 5.673 | 10.733 | 12.888 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.016 | 72.778 | -3.652 | 506 | 29.699 | -2.841 |
| Net Profit/Loss - EUR | - | - | - | - | 6.805 | 70.784 | -3.652 | 449 | 29.303 | -3.808 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Amarisia Intl Medical Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 1.021 | 499 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 7.227 | 72.674 | 274 | 4.436 | 28.945 | 13.543 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 6.043 | 35.143 | 5 | 0 | 20.742 | 1.001 |
| Cash | - | - | - | - | 1.184 | 37.531 | 269 | 4.436 | 8.203 | 12.543 |
| Shareholders Funds | - | - | - | - | 6.847 | 70.834 | -3.604 | -3.166 | 26.147 | 6.110 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 380 | 860 | 3.878 | 7.602 | 2.798 | 7.475 |
| Income in Advance | - | - | - | - | 0 | 2.001 | 499 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Amarisia Intl Medical Research S.r.l.